The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines
Abstract
Abstract Biofilm formation in Staphylococcus aureus causes an increase in antibiotics resistance in chronic diseases, including osteomyelitis, endocarditis, and wound infection. The S. aureus biofilm structure is composed of polysaccharide, protein, and external DNA. Bacterial cells in the biofilm compose of resistant persister cells and exhibit multidrug resistance. The emergence of multidrug resistant S. aureus strains is a health problem now. In the S. aureus biofilm state, susceptibility to antibiotics even vancomycin is reduced and eradication of bacteria is challenging. In the present review, we studied the structure of biofilm, antibiotic resistant in biofilm state, and biofilm prevention strategies in S. aureus. Infections due to S. aureus are expensive and susceptibility to antibiotics is reduced in biofilm state and several methods, including anti-biofilm agents and vaccine should be applied to treat diseases related to biofilm. For prevention and inhibition of biofilm, application of antiadhesion agents and vaccines based on biofilm genes is recommended. Multivalent vaccines based on biofilm genes, including clumping factor A, poly-β (1-6)-N-acetylglucosamine, collagen adhesin, and fibronectin binding protein in S. aureus can be beneficial for preventing initial attachment and biofilm formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Surface coatings (GL13K peptide, AGXX®) reduce bacterial adhesion by 40–94% on medical devices [298,300].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [300]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues
Cheng, A. G., Kim, H. K., Burts, M. L., Krausz, T., Schneewind, O., & Missiakas, D. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-135467 · Cited by 437
RetractedTong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
MSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Kaplan, J. B., Velliyagounder, K., Ragunath, C., Rohde, H., Mack, D., Knobloch, J. K.-M., & Ramasubbu, N. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8213-8220.2004 · Cited by 301
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Benito, N., Miró, J. M., de Lazzari, E., Cabell, C. H., del Río, A., Altclas, J., Commerford, P., Delahaye, F., Dragulescu, S., Giamarellou, H., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00004 · Cited by 277
Where does a Staphylococcus aureus vaccine stand?
Fowler, V. G., & Proctor, R. A. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12570 · Cited by 241
Ganeshnarayan, K., Shah, S. M., Libera, M. R., Santostefano, A., & Kaplan, J. B. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01900-08 · Cited by 51
Research works printed but not linked: 72
- Anderson, 2016, Staphylococcus aureus clumping factor A remains a viable vaccine target for prevention of S. aureus infection, mBio, 7, 10.1128/mBio.00225-16 · DOI
- Ansari, 2017, Antimicrobial resistant determination and prokaryotic expression of smpA gene of Acinetobacter baumannii isolated from admitted patients, Jundishapur J. Microbiol., 10, 10.5812/jjm.59370 · doi:10.5812/jjm.59370
- Ansari, 2019, Recent advances in Staphylococcus aureus infection: focus on vaccine development, Infection Drug Resis., 12, 1243, 10.2147/IDR.S175014 · DOI
- Archer, 2011, Staphylococcus aureus biofilms properties, regulation and roles in human disease, Virulence, 2, 445, 10.4161/viru.2.5.17724 · DOI · Paper page
- Arciola, 2015, Polysaccharide intercellular adhesion in biofilm: structural and regulatory aspects, Front. Cell. Infect. Microbiol., 5, 1, 10.3389/fcimb.2015.00007 · DOI · Paper page
- Asadi, 2014, The association of virulence determinants of uropathogenic Escherichia coli with antibiotic resistance, Jundishapur J. Microbiol., 7
- Bashore, 2006, Update on infective endocarditis, Curr. Probl. Cardiol., 31, 274, 10.1016/j.cpcardiol.2005.12.001 · DOI · Paper page
- Bhattacharya, 2015, Prevention and treatment of Staphylococcus aureus biofilms, Expert Rev. Anti-Infect. Ther., 13, 1499, 10.1586/14787210.2015.1100533 · DOI · Paper page
- Boles, 2011, Staphylococcal biofilms disassembly, Trends Microbiol., 19, 449, 10.1016/j.tim.2011.06.004 · DOI · Paper page
- Cerca, 2008, Regulation of the intercellular adhesion locus regulator (ica R) by SarA, SigmaB,and IcaR in Staphylococcus aureus, J. Bacteriol., 190, 6530, 10.1128/JB.00482-08 · DOI
- Chancey, 2012, Acquired inducible antimicrobial resistance in Gram-positive bacteria, Future Microbiol., 7, 959, 10.2217/fmb.12.63 · DOI
- Costerton, 1978, How bacteria stick, Sci. Am., 238, 86, 10.1038/scientificamerican0178-86 · DOI · Paper page
- Cue, 2009, Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of ica ADBC, J. Bacteriol., 191, 6363, 10.1128/JB.00913-09 · DOI
- Denis, 2017, Route of transmission of Staphylococcus aureus, Lancet Infect. Dis., 17, 117, 10.1016/S1473-3099(16)30512-6 · DOI
- Eriksson, 2017, Antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis, BJD, 177, 513, 10.1111/bjd.15410 · DOI
- Fischer, 1996, Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion, J. Orthop. Res., 14, 914, 10.1002/jor.1100140611 · DOI
- Fisher, 2017, Persistent bacterial infections and persister cells, Nat. Rev. Microbiol., 15, 453, 10.1038/nrmicro.2017.42 · DOI · Paper page
- Foster, 2014, Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
- Ghorbani-Dalinia, 2015, Molecular epidemiology of ESBLs genes and multi-drug resistance in diarrheagenic Escherichia Coli strains isolated from adults in Iran, Iranian J. Pharmaceut. Res., 14, 1257
- Giersing, 2016, Status of vaccine research and development of vaccines for Staphylococcus aureus, Vaccine, 34, 2962, 10.1016/j.vaccine.2016.03.110 · DOI
- Harro, 2010, Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration, FEMS Immunol. Med. Microbiol., 59, 306, 10.1111/j.1574-695X.2010.00708.x · DOI
- Hassett, 1999, Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide, Mol. Microbiol., 34, 1082, 10.1046/j.1365-2958.1999.01672.x · DOI · Paper page
- Hogan, 2008, Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents, Antimicrob. Agents Chemother., 62
- HΦiby, 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
- Ivanova, 2018, Layer-by-layer decorated nanoparticles with tunable antibacterial and antibiofilm properties against both Gram-positive and Gram-negative bacteria, ACS Appl. Mater. Interfaces, 10, 3314, 10.1021/acsami.7b16508 · DOI
- Jefferson, 2004, The teicoplanin-associated locus regulator (Tca R) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus, J. Bacteriol., 186, 2449, 10.1128/JB.186.8.2449-2456.2004 · DOI · Paper page
- Josefsson, 2001, Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant, J. Infect. Dis., 184, 1572, 10.1086/324430 · DOI · Paper page
- Kargar, 2012, Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders, Res. Microbiol., 163, 109, 10.1016/j.resmic.2011.11.005 · DOI
- Kargar, 2014, Resistance to different generations of quinolones in Streptococcus pneumoniae strains isolated from hospitals in Shiraz, Comp. Clin. Pathol., 24
- Kargar, 2014, High prevalence of class 1 to 3 integrons among multidrug-resistant diarrheagenic Escherichia coli in southwest of Iran, Osong Public Health Res. Perspect., 5, 193, 10.1016/j.phrp.2014.06.003 · DOI
- Khan, 2015, Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections, Expert Opin. Investig. Drugs, 24, 689, 10.1517/13543784.2015.1019062 · DOI
- Lasa, 2006, Bap: a family of surface proteins involved in biofilm formation, Res. Microbiol., 157, 99, 10.1016/j.resmic.2005.11.003 · DOI · Paper page
- Levy, 2015, Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03 adjuvant: results of a randomized phase I trial, Hum. Vaccin. Immunother., 11, 620, 10.1080/21645515.2015.1011021 · DOI
- Li, 2018, Biological characteristics and conjugated antigens of Clf A-FnBPA and CP5 in Staphylococcus aureus, Can. J. Vet. Res., 82, 48
- Liu, 2018, The influence of cell and substratum surface on hydrophobicities on microbial attachment, J. Biotechnol., 110, 251, 10.1016/j.jbiotec.2004.02.012 · DOI · Paper page
- Lu, 2007, Dispersing biofilms with engineered enzymatic bacteriophage, PNAS, 104, 11197, 10.1073/pnas.0704624104 · DOI · Paper page
- Maira-Litrán, 2002, Immunochemical properties of the Staphylococcal N-acetylglucosamine surface polysaccharide, Infect. Immun., 70, 4433, 10.1128/IAI.70.8.4433-4440.2002 · DOI · Paper page
- Maira-Litrán, 2012, Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A, PLOS, 7
- Mashruwala, 2017, Impaired respiration elicits Srr AB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureus, eLife, 6, 10.7554/eLife.23845 · DOI · Paper page
- McDonald, 1970, Immunochemical analysis of a uronic acid polymer of Staphylococcus Epidermidis, strain 53, Karakawa J. Immunol., 105, 389, 10.4049/jimmunol.105.2.389 · doi:10.4049/jimmunol.105.2.389
- McGuiness, 2017, Vancomycin resistance in Staphylococcus aureus, YJBM, 90, 269
- McKenney, 1999, Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen, Science, 284, 1523, 10.1126/science.284.5419.1523 · DOI · Paper page
- Morris, 2018, Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus, Surg. Infect., 20
- Mulcahy, 2016, Host–bacterial crosstalk determines Staphylococcus aureus nasal colonization, Trends Microbiol., 24, 872, 10.1016/j.tim.2016.06.012 · DOI
- Murugan, 2010, Biofilm forming multidrug resistant Staphylococcus spp. among patients with conjunctivitis, Pol. J. Microbiol., 59, 233, 10.33073/pjm-2010-036 · DOI
- Nissen, 2015, A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults, Vaccine, 33, 1846, 10.1016/j.vaccine.2015.02.024 · DOI
- O’Rourke, 2014, Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway, PLoS One, 9, 10.1371/journal.pone.0111198 · DOI
- Pamp, 2006, Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus, J. Bacteriol., 188, 4861, 10.1128/JB.00194-06 · DOI · Paper page
- Panda, 2020, Indian medicinal plant extracts to control multidrug-resistant S. aureus, including in biofilms, S. Afr. J. Bot., 128, 283, 10.1016/j.sajb.2019.11.019 · doi:10.1016/j.sajb.2019.11.019
- Pappelbaum, 2013, Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress, Circulation, 128, 50, 10.1161/CIRCULATIONAHA.113.002008 · DOI
- Parastan, 2020, A synergistic association between adhesion-related genes and multidrug resistance patterns of Staphylococcus aureus isolates from different patients and healthy individuals, JGAR
- Peters, 2010, Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms, FEMS Immunol. Med. Microbiol., 59, 493, 10.1111/j.1574-695X.2010.00710.x · DOI · Paper page
- Piroth, 2008, The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis, Infect. Immun., 76, 3824, 10.1128/IAI.00405-08 · DOI
- Poulsen, 1993, Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms, Appl. Environ. Microbiol., 59, 1354, 10.1128/aem.59.5.1354-1360.1993 · DOI · Paper page
- Rao, 2011, Treating osteomyelitis: antibiotics and surgery, Plast. Reconstr. Surg., 127, 177S, 10.1097/PRS.0b013e3182001f0f · DOI · Paper page
- Rhem, 2000, The collagen-binding Adhesin is a virulence factor in Staphylococcus aureus keratitis, Infect. Immun., 68, 3776, 10.1128/IAI.68.6.3776-3779.2000 · DOI
- Sass, 2007, Lytic activity of recombinant bacteriophage Φ11 and Φ12 endolysins on whole wells and biofilms of Staphylococcus aureus, Appl. Environ. Microbiol., 73, 347, 10.1128/AEM.01616-06 · DOI · Paper page
- Schuch, 2017, Bacteriophage Lysin CF-301, a potent antistaphylococcal biofilm agent, Antimicrob. Agents Chemother., 61, 10.1128/AAC.02666-16 · DOI · Paper page
- Scully, 2018, O-acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide, Hum. Vaccin. Immunother., 14, 81, 10.1080/21645515.2017.1386360 · doi:10.1080/21645515.2017.1386360
- Serra, 2015, Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus, Expert Rev. Anti-Infect. Ther., 13, 605, 10.1586/14787210.2015.1023291 · DOI · Paper page
- Sharma, 2018, Phage-derived lysins as potential agents for eradicating biofilms and persisters, Drug Discov. Today, 23, 848, 10.1016/j.drudis.2018.01.026 · DOI
- Shenkman, 2002, Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions, J. Med. Microbiol., 51, 747, 10.1099/0022-1317-51-9-747 · doi:10.1099/0022-1317-51-9-747
- Shirtliff, 2009, Cross-kingdom interactions: Candida albicans and bacteria, FEMS Microbiol. Lett., 299, 1, 10.1111/j.1574-6968.2009.01668.x · DOI · Paper page
- Shokravi, 2015, Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus, BI, 5, 87, 10.15171/bi.2015.15 · DOI · Paper page
- Siboo, 2005, Role of SraP, a serine-rich surface protein of Staphylococcus aureus in binding to human platelets, Infect. Immun., 73, 2273, 10.1128/IAI.73.4.2273-2280.2005 · DOI · Paper page
- Singh, 2018, In silico identification of albendazole as a quorum sensing inhibitor and its in vitro verification using CviR and Las B receptors based assay systems, BI, 8, 201, 10.15171/bi.2018.23 · DOI
- Stewart, 2003, Diffusion in biofilms, J. Bacteriol., 185, 1485, 10.1128/JB.185.5.1485-1491.2003 · DOI · Paper page
- Tuomanen, 1986, The rate of killing of Escherichia coli by beta lactam antibiotics is strictly proportional to the rate of bacterial growth, J. Gen. Microbiol., 132, 1297
- Vaishampayan, 2018, A novel antimicrobial coating represses biofilm and virulence-related genes in methicillin-resistant Staphylococcus aureus, Front. Microbiol., 9, 221, 10.3389/fmicb.2018.00221 · DOI
- Xu, 2017, Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: a meta-analysis of randomized controlled trials(?), Hum. Vaccin. Immunother., 14, 314, 10.1080/21645515.2017.1395540 · doi:10.1080/21645515.2017.1395540
- Yarwood, 2004, Quorum sensing in Staphylococcus aureus biofilms, J. Bacteriol., 186, 1838, 10.1128/JB.186.6.1838-1850.2004 · DOI · Paper page
- Zhou, 2006, An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model, Vaccine, 24, 4830, 10.1016/j.vaccine.2006.03.020 · DOI
Cited by
Biofilm Formation and Control of Foodborne Pathogenic Bacteria
Liu, X., Yao, H., Zhao, X., & Ge, C. (2023) · Molecules · doi:10.3390/molecules28062432 · Cited by 297
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Tang, Y., Deng, H., Xu, Z., Yu, Z., Xiang, Y., Wen, Z., Han, S., Chen, Z., & Hou, T. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04104-2 · Cited by 4
Metadata
- Authors
- Parastan, R., Kargar, M., Solhjoo, K., & Kafilzadeh, F.
- ORCID
- Kargar, Mohammad
- Venue
- Gene Reports
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 20
- Pages
- 100739
- ISSN
- 2452-0144
- Cited by
- 93
- References
- 8
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Islamic Azad University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.